Free Trial
NASDAQ:TEM

Tempus AI (TEM) Stock Price, News & Analysis

Tempus AI logo
$34.91 -0.63 (-1.77%)
(As of 05:45 PM ET)

About Tempus AI Stock (NASDAQ:TEM)

Key Stats

Today's Range
$33.42
$36.80
50-Day Range
$33.03
$77.62
52-Week Range
$22.89
$79.49
Volume
3.43 million shs
Average Volume
1.60 million shs
Market Capitalization
$5.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$56.00
Consensus Rating
Moderate Buy

Company Overview

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

Tempus AI Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
55th Percentile Overall Score

TEM MarketRank™: 

Tempus AI scored higher than 55% of companies evaluated by MarketBeat, and ranked 489th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tempus AI has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 9 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Tempus AI has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Tempus AI's stock forecast and price target.
  • Earnings Growth

    Earnings for Tempus AI are expected to grow in the coming year, from ($6.15) to ($1.33) per share.

  • Percentage of Shares Shorted

    10.29% of the float of Tempus AI has been sold short.
  • Short Interest Ratio / Days to Cover

    Tempus AI has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Tempus AI has recently increased by 22.25%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Tempus AI does not currently pay a dividend.

  • Dividend Growth

    Tempus AI does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.29% of the float of Tempus AI has been sold short.
  • Short Interest Ratio / Days to Cover

    Tempus AI has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Tempus AI has recently increased by 22.25%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Tempus AI has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 25 news articles for Tempus AI this week, compared to 8 articles on an average week.
  • Search Interest

    42 people have searched for TEM on MarketBeat in the last 30 days. This is an increase of 56% compared to the previous 30 days.
  • MarketBeat Follows

    38 people have added Tempus AI to their MarketBeat watchlist in the last 30 days. This is an increase of 90% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tempus AI insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $35,125,473.00 in company stock.

  • Percentage Held by Institutions

    Only 24.22% of the stock of Tempus AI is held by institutions.

  • Read more about Tempus AI's insider trading history.
Receive TEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tempus AI and its competitors with MarketBeat's FREE daily newsletter.

TEM Stock News Headlines

Tempus AI medical research
Tempus AI: A Potential Double-Bagger After Recent Pullback
AI healthcare stock Tempus AI has seen its value fall off a cliff recently. However, Wall Street remains bullish, seeing significant upside in the shares.
Is Jeff Bezos Crowning the Next Nvidia?
It doesn't matter what you think about AI... Because Jeff Bezos's massive load-up on one tiny tech company just changed the game entirely. The company bringing what I call "QaaS" to the masses could dominate the industry and make an absolute killing.
10 AI News Investors Shouldn’t Miss
See More Headlines

TEM Stock Analysis - Frequently Asked Questions

Tempus AI's stock was trading at $36.48 at the beginning of the year. Since then, TEM shares have decreased by 4.3% and is now trading at $34.91.
View the best growth stocks for 2024 here
.

Tempus AI (TEM) raised $411 million in an IPO on Friday, June 14th 2024. The company issued 11,100,000 shares at a price of $37.00 per share.

Tempus AI's lock-up period expired on Wednesday, December 11th. Tempus AI had issued 11,100,000 shares in its IPO on June 14th. The total size of the offering was $410,700,000 based on an initial share price of $37.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the end of the lock-up period.

Tempus AI's top institutional investors include NEA Management Company LLC (3.49%), ARK Investment Management LLC (1.54%), Sumitomo Mitsui Trust Group Inc. (0.79%) and Franklin Resources Inc. (0.52%). Insiders that own company stock include Bradley A Keywell, Eric P Lefkofsky, Ryan Fukushima, Andrew Polovin, James William Rogers and Ryan M Bartolucci.
View institutional ownership trends
.

Shares of TEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tempus AI investors own include AST SpaceMobile (ASTS), NVIDIA (NVDA), Broadcom (AVGO), Micron Technology (MU), Recursion Pharmaceuticals (RXRX), Genius Sports (GENI) and Super Micro Computer (SMCI).

Company Calendar

Today
12/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Computer programming, data processing, & other computer related
Sub-Industry
Computer Software
Current Symbol
NASDAQ:TEM
Previous Symbol
NASDAQ:TEM
Fax
N/A
Employees
2,300
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$56.00
High Stock Price Target
$74.00
Low Stock Price Target
$44.00
Potential Upside/Downside
+60.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

Net Income
$-289,810,000.00
Pretax Margin
-190.28%

Debt

Sales & Book Value

Annual Sales
$640.44 million

Miscellaneous

Free Float
N/A
Market Cap
$5.50 billion
Optionable
N/A
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (NASDAQ:TEM) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners